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ABSTRACT
Background: Mild cognitive impairment (MCI) is
considered to represent a transitional stage between
ageing and Alzheimer’s disease (AD). To aim at
identifying neuroimaging measures associated with
cognitive changes in healthy elderly and MCI patients,
longitudinal multicentre studies are ongoing in several
countries. The patient proﬁles of each study are based
on unique inclusion criteria.
Objectives: The purpose of the study is to clarify
differences in baseline proﬁles of MCI patients
between Studies on Diagnosis of Early Alzheimer’s
DiseasedJapan (SEAD-J) and Alzheimer’s Disease
Neuroimaging Initiative (ADNI) and to examine the
association between baseline proﬁles and risk of early
conversion to AD.
Design: Prospective cohort study.
Setting and participants: SEAD-J recruited 114
patients from nine facilities in Japan. A total of 200
patients in ADNI with ﬂuorodeoxyglucoseepositron
emission tomography (FDG-PET) were enrolled from
the USA.
Methods: Baseline proﬁles were statistically analysed.
For FDG-PET at a time of inclusion, associations
between each proﬁle and cerebral metabolic rate for
glucose (CMRgl) were examined using SPM5 software.
In each study, the ratio of conversion to AD within the 1-
year and 2-year period after inclusion was investigated
and differences in baseline proﬁles between AD
converters and non-converters were analysed.
Results: SEAD-J included MCI patients with more
severe verbal memory deﬁcits and extracted patients
with higher depressive tendencies. These differences
were likely to be associated with criteria. SEAD-J
exhibited a higher rate of conversion within 1 year
compared with ADNI (24.5% vs 13.5%). In FDG-PET
analyses of SEAD-J, AD converters within 1 year
showed more severe decrease of FDG uptake in bilateral
inferior parietal regions compared with non-converters.
Conclusions: Different inclusion criteria provided
differences in baseline proﬁles. The severity of
memory deﬁcit might cause increase of the AD
conversion within 1 year. Clinical outcomes of
multicentre studies for early diagnosis of AD should be
interpreted carefully considering proﬁles of patients.
INTRODUCTION
The increasing prevalence of patients with
dementia is a growing social problem. In
particular, Alzheimer’s disease (AD) is a
common disease that causes progressive
dementia. Mild cognitive impairment (MCI) is
considered to represent a transitional stage
between ageing and AD,
1 and patients with
MCI tend to progress to AD at a rate of
approximately 10%e15% per year.
23In this
context, early diagnosis of patients who show
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ARTICLE SUMMARY
Article focus
- To aim at identifying neuroimaging measures
associated with cognitive changes in healthy
elderly and MCI patients, longitudinal multicentre
studies are ongoing in several countries.
- The differences in baseline proﬁles of MCI
patients between Studies on Diagnosis of Early
Alzheimer’s DiseasedJapan (SEAD-J) and
Alzheimer’s Disease Neuroimaging Initiative
(ADNI) multicentre studies are clariﬁed.
Key messages
- In association with criteria, SEAD-J recruited more
patients with pre-dementia AD who had severe
verbal memory deﬁcits compared with ADNI.
- In SEAD-J, AD converters within 1 year showed
more severe decrease of FDG uptake in bilateral
inferior parietal regions compared with non-
converters. SEAD-J exhibited a higher rate of
conversion within 1 year.
- These results suggested that MCI patients with
severe memory loss at the time of inclusion had
an increased risk of early transition to AD.
Strengths and limitations of this study
- This study reinforces that the results of multi-
centre studies should be interpreted carefully
considering the impact of baseline proﬁles.
- The present results were based on the analysis of
data at the time of inclusion.
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Open Access Researchan increased risk of future conversion to AD represents an
important step towards preventing progression of AD
pathology when disease-modifying therapies for AD are
ﬁnally developed.
Although the clinical evidence is not yet well estab-
lished, ﬂuorodeoxyglucoseepositron emission tomog-
raphy (FDG-PET) has recently been reported to provide
useful ﬁndings of the cerebral metabolic rate for glucose
(CMRgl) in both patients with AD
4 5 and MCI patients.
6
A pattern of CMRgl reduction in the posterior cingulate
cortex and precuneus has been reported in MCI
patients,
7 and hypometabolism in these regions might
contribute to prediction of clinical AD conversion.
8
Furthermore, AD converters from among pre-MCI
patients have shown correlations between CMRgl and
future memory decline.
9 Likewise, FDG-PET appears
potentially useful for distinguishing MCI patients with
increased risk of progressive dementia from patients
with lower risk of future AD conversion.
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
is a multicentre study aimed at identifying neuroimaging
measures and biomarkers associated with cognitive and
functional changes in healthy elderly, MCI and AD
subjects.
10 ADNI was launched in 2003 by the National
Institute on Aging, the National Institute of Biomedical
Imaging and Bioengineering, the Food and Drug
Administration, private pharmaceutical companies and
non-proﬁt organisations, as a $60 million 5-year
publiceprivate partnership. ADNI is the results of efforts
by many co-investigators from a broad range of academic
institutions and private corporations, and subjects have
been recruited from over 50 sites across the USA and
Canada (for additional information about ADNI, see
http://www.adni-info.org). Studies on Diagnosis of Early
Alzheimer’s DiseasedJapan (SEAD-J) was launched in
2005 by the National Center for Geriatrics and Geron-
tology. SEAD-J represents an ongoing follow-up of MCI
patients, with the aim of achieving early prediction of AD
conversion. Both studies have been investigating
changes of serial neuroimaging ﬁndings and neuro-
psychological assessments, based on different patient
samples enrolled with unique inclusion criteria to
extract patients at increased risk of AD. Such differences
in criteria appear likely to affect AD conversion.
11
However, the impact of difference in baseline proﬁles of
MCI patients for AD conversion has not been studied
yet. The purpose of the study was to clarify this,
comparing the results of statistical and imaging analyses
of different multicentre studies: SEAD-J and ADNI. We
investigated baseline proﬁles and AD conversion ratio
within the 1-year and 2-year period after inclusion and
then statistically analysed differences in baseline proﬁles
between AD converters and non-converters.
MATERIALS AND METHODS
SEAD-J participants
Data set of SEAD-J was obtained from nine facilities in
Japan. All data were checked and quality controlled at
National Center for Geriatrics and Gerontology. A total
of 114 patients with MCI (mean age (6SD),
70.867.5 years; 50 men, 64 women) were enrolled. A
total of 56 normal age-matched subjects (20 men and 36
women) without evidence of neuropsychiatric impair-
ment based on interviews were included to construct
a normative imaging database. All participants provided
informed consent in accordance with the trust ethics
committee of National Center for Geriatrics and
Gerontology. All data sets of clinical and FDG-PET
ﬁndings over a follow-up period of 2 years have acquired.
Diagnosis of MCI was based on an interview with
neurologists that contained evidence of reduced cogni-
tive capacity, normal activities of daily living and absence
of dementia.
12 All patients were free of signiﬁcant
underlying medical, neurological or psychiatric illness.
Patients were initially accessed using a neuro-
psychological test battery, including Mini-Mental Status
Examination (MMSE), Clinical Dementia Rating
(CDR),
13 Geriatric Depression Scale (GDS)
14 15 and
Logical Memory subset of the Wechsler Memory Scale
Revised (WMS-R LM).
16 In accordance with the inclu-
sion criteria, MCI patients were between 50 and 80 years
old, with an MMSE score $24, a GDS score #10, a WMS-
R LM I score #13, an LM II parts A and part B score
(maximum, 50) #8 and a CDR memory box score
restricted to 0.5. Patients with an educational level,
deﬁned as the number of completed years of formal
education, <6 years were excluded.
ADNI participants
Data used in the preparation of this article were
obtained from the ADNI Database (http://www.loni.
ucla.edu/ADNI). Data sets of clinical and baseline FDG-
PET recruited from a total of 200 MCI patients (mean
age, 75.267.1 years; 134 men, 66 women) were down-
loaded from the ADNI public website (http://www.loni.
ucla.edu/ADNI/). Data sets of baseline FDG-PET from
102 normal subjects were used as reference data to
perform group comparisons of FDG-PET between these
studies. MCI patients were without any other neuro-
psychological disease or symptoms and between 55 and
90 years old, with an MMSE score $24, verbal memory
deﬁcit as measured by WMS-R LM II part A score
(maximum, 25) and a CDR memory box score 0.5 or 1.
LM II part A score was used to select patients with verbal
memory deﬁcit measured by education-adjusted scores
#8/25 (for $16 years of education, n¼133), #4/25 (for
8e15 years of education, n¼66) or #2/25 (for #7 years
of education, n¼1). In addition, patients who had
experienced major depression or bipolar disorder within
the past year were excluded, and patients with
a Hamilton Depression Rating Scale
17 score #12 (from
a total of 17 items) were recruited.
Neuropsychological test batteries
The neuropsychological test batteries used in each study
had three differences, regarding MMSE, WMS-R LM II
and GDS scores. In different subscores of MMSE,
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Comparison of baseline proﬁles of MCI patients between SEAD-J and ADNIpatients in SEAD-J were scored using serial subtraction
of 7 from 100 (5 points), while patients in ADNI were
scored by reverse repetition of the word ‘earth’ (5
points). To adjust for this difference, modiﬁed MMSE
score (maximum, 25) was calculated without the
subscores from these 5-point subsets.
WMS-R LM II score contains parts A and B and reﬂects
verbal memory deﬁcits. The total score is 50 points. In
SEAD-J, the cut-off score of WMS-R LM II for inclusion
was #8/50. In ADNI, it was determined using the algo-
rithm described above. For comparison of both proﬁles,
only part A score (25 points) was used for analysis, and
the normalised cut-off score for inclusion were calcu-
lated using a following calculation that took into account
each weighting for the educational level: + (cut-off score
3 patient number of each category)/total patient
number. Using this measurement, the normalised cut-off
score for ADNI was estimated as #6.65/25, while that for
SEAD-J was #4/25. The difference also indicated that
SEAD-J used more severe criteria to include patients with
memory deﬁcits.
To evaluate depressive tendencies, ADNI used the
Hamilton Depression Rating Scale and GDS, while
SEAD-J used a 15-item questionnaire (GDS-15). A higher
GDS score ($11) reﬂects depressive tendencies and
represents a reliable instrument to diagnose depressive
disorder.
14 15 GDS-15 was considered a suitable short-
form test for an elderly population.
18 A higher GDS-15
score ($6) was evaluated as having >90% sensitivity and
speciﬁcity for depression in elderly individuals.
19
FDG-PET and analyses
In SEAD-J, FDG-PET data at the time of inclusion were
consolidated onto local servers. Scans were performed in
a resting state in a dark room, 40e60 min after venous
injection of FDG. Scans of MCI patients were compared
with a normative reference database, controlling for
global activity using iSSP software (http://MediPhysics.
com) and then Z scores of FDG uptake were calculated
voxel by voxel.
Three-dimensional stereotactic surface projections
20
of Z scores were generated to visualise imaging differ-
ences for MCI patients compared with age-matched
controls and AD converters compared with age-matched
controls. In line with the same procedure mentioned
above, we performed a comparison for scans of MCI
patients in ADNI, using data sets restricted to partici-
pants <80 years old, to reduce differences in age for
comparisons of results.
We also performed correlation analyses to investigate
the impact of baseline patient proﬁles on CMRgl
reduction using SPM5 software (http://www.ﬁl.ion.ucl.
ac.uk/spm/). Each image was deformed to the Montreal
Neurological Imaging template and then normalised for
variations in whole-brain measurements using propor-
tionate scaling. Post-processed images were smoothed to
a spatial resolution of 8 mm full width at half maximum.
Analyses were conducted using MMSE score, WMS-R LM
II score, GDS score and age as independent variables
and CMRgl as the dependent variable. Statistical para-
metric maps for each of the contrasts and correlations
were used in computations. The level of signiﬁcance was
set at p<0.01 (uncorrected).
Statistical analyses
SPSS V.17.0 was used for the analyses of baseline proﬁles.
Independent sample t-tests were used to assess differ-
ences in clinical and cognitive variables. The c
2 test was
used for the analysis of gender difference between
studies and used to determine group differences in the
ratio of AD conversion (AD converters vs non-converters;
MCI stables) within the 1-year and 2-year period after
inclusion.
RESULTS
Differences in criteria and clinical proﬁles
The inclusion criteria of SEAD-J and ADNI and the
differences in demographic characteristics of MCI
patients are summarised in tables 1 and 2. In compari-
sons of neuropsychological test batteries at the time of
inclusion, mean MMSE score was lower for SEAD-J
patients (26.461.9) than for ADNI patients (27.261.7,
p<0.001), and mean WMS-R LM score was lower for
SEAD-J patients (1.861.8) than for ADNI patients
(4.062.7, p<0.001). However, modiﬁed MMSE score did
not differ signiﬁcantly between studies, suggesting that
there is little difference in global cognitive function
compared with verbal memory deﬁcits.
MCI patients in SEAD-J showed a lower educational
level (SEAD-J, 11.563.0 years; ADNI, 15.862.9 years,
p<0.001). The percentage of patients with education
level $16 years (corresponding to post-university) was
18.4% in SEAD-J and 66.5% in ADNI, indicating the
inclusion of a larger proportion of patients with higher
education in ADNI. A positive correlation between WMS-
R LM score and education level was found in ADNI
patients (r¼0.30, p<0.001) but not in SEAD-J patients
Table 1 Differences in inclusion criteria for mild cognitive
impairment
SEAD-J ADNI
Age (yrs) 50e80 55e90
MMSE 24e30 24e30
CDR memory 0.5 0.5 or 1
WMS-R LM I 0e13 None
WMS-R LM II 0e8*
GDS 0e10 None
HAM-D None 0e12
*See the Materials and methods section.
ADNI, Alzheimer’s Disease Neuroimaging Initiative; CDR memory,
memory subscore for Clinical Dementia Rating; GDS, Geriatric
Depression Scale; HAM-D, Hamilton Depression Rating Scale;
MMSE, Mini-Mental Status Examination; SEAD-J, Studies on
Diagnosis of Early Alzheimer’s DiseasedJapan; WMS-R LM II,
Logical Memory part II subset of the Wechsler Memory Scale
Revised; WMS-R LM I, Logical Memory part I subset of the
Wechsler Memory Scale Revised.
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Comparison of baseline proﬁles of MCI patients between SEAD-J and ADNI(r¼0.04, p¼0.67). No association with MMSE scores was
found in either study.
Regarding depressive tendencies using GDS, mean
score was higher in SEAD-J patients (4.362.2) than in
ADNI patients (1.661.4, p<0.001). In SEAD-J, 18
patients (9%) were over the cut-off for GDS-15 (6/15
points), while in ADNI, no patients were over the cut-off
(11/30 points). Thus, SEAD-J included more patients
with higher depressive tendency compared with ADNI.
The difference in GDS score might have been caused by
the exclusive criteria using the Hamilton Depression
Rating Scale. The mean age of patients was younger in
SEAD-J (70.867.5 years) compared with ADNI
(75.267.1 years, p<0.001), presumably due to the
inclusion criteria for age.
Baseline FDG-PET: group comparisons and correlation
analyses
Compared with normal controls, MCI patients in SEAD-J
showed considerably lower CMRgl in the regions pref-
erentially affected by AD, including the precuneus,
posterior cingulate and parietotemporal regions (AD-
associated hypometabolism) (ﬁgure 1A). In ADNI, MCI
patients exhibited similar patterns of reduced CMRgl in
these regions. The CMRgl reduction was also found in
medial temporal regions with left dominance (ﬁgure
1B). In both studies, MCI patients showed lower CMRgl
in bilateral frontal regions compared with normal
subjects. Furthermore, in SEAD-J, FDG-PET analysis
revealed that the converters during 1 year after inclusion
showed AD-associated hypometabolism compared with
non-converters. The difference in hypometabolism was
more severe in the converters within 1 year compared
with the converters within the following 1 year (ﬁgure 2).
In correlation analyses for FDG-PET, the association
between patient proﬁles and glucose metabolism are
depicted in ﬁgures 3 and 4. In SEAD-J, bilateral inferior
parietal regions correlated with MMSE score, whereas
ADNI showed no speciﬁc regions (ﬁgure 3A). Both
studies showed different patterns of correlation with
WMS-R LM score. In SEAD-J, a correlation was found in
the left inferior parietal region, while ADNI showed
Table 2 Demographic characteristics of patients at the
time of inclusion
SEAD-J ADNI p Value
Age (yrs) 70.867.5 75.267.1 <0.001
Gender (M:F) 50:64 134:66 <0.001
Education (yrs) 11.563.0 15.862.9 <0.001
MMSE 26.461.9 27.261.7 <0.001
Modiﬁed MMSE 22.461.7 22.561.5 0.642
WMS-R LM 1.861.8 4.062.7 <0.001
GDS 4.362.2 1.661.4 <0.001
Values are mean6SD. The Modiﬁed MMSE represents the sum of
total scores except for different subscores in both studies
(maximum 25). WMS-R LM is taken as the score for the Logical
Memory II part A (maximum 25).
ADNI, Alzheimer’s Disease Neuroimaging Initiative; GDS, Geriatric
Depression Scale; MMSE, Mini-Mental Status Examination; SEAD-
J, Studies on Diagnosis of Early Alzheimer’s DiseasedJapan;
WMS-R LM, Logical Memory subset of the Wechsler Memory
Scale Revised.
Figure 1 3D-SSP analyses of
baseline ﬂuorodeoxyglucosee
positron emission tomography in
Studies on Diagnosis of Early
Alzheimer’s DiseasedJapan
(SEAD-J) (A) and Alzheimer’s
Disease Neuroimaging Initiative
(ADNI) (B). These are the results
of group comparison between MCI
patients and normal controls (NC).
MCI patients showed a signiﬁcant
decrease of the cerebral metabolic
rate for glucose (CMRgl) not only
in the regions preferentially
affected by Alzheimer’s disease
(including the inferior parietal
lobules and precuneus) but also in
the frontal lobules. Colour bar
indicates the mean Z score of
CMRgl. LAT, lateral view; SUP,
superior view; INF, inferior view;
ANT, anterior view; POST,
posterior view; MED, medial view;
GLB, reference region in global
brain; CLB, reference region in
cerebellum.
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Comparison of baseline proﬁles of MCI patients between SEAD-J and ADNIcorrelations in the precuneus and left medial temporal
region (ﬁgure 3B). Furthermore, GDS score showed an
inverse correlation in the frontal regions. In SEAD-J,
regions with signiﬁcant correlations showed a greater
distribution over the lateral and inferior frontal regions
(ﬁgure 4A). As for correlations with age, both studies
Figure 2 3D-SSP analyses of
baseline ﬂuorodeoxyglucosee
positron emission tomography in
Studies on Diagnosis of Early
Alzheimer’s DiseasedJapan.
These are the results of group
comparisons between Alzheimer’s
disease (AD) converters and non-
converters. AD converters show
a greater reduction in glucose
metabolism for AD-associated and
frontal regions. This
hypometabolism was more
evident in the converters within
1 year after inclusion compared
with the converters from 1 year to
2 years after inclusion. (A) AD
converters within 1 year after
inclusion and non-converters. (B)
AD converters from 1 year to
2 years after inclusion and non-
converters.
Figure 3 Statistical parametric
mapping of the brain regions
correlated with baseline proﬁles in
Studies on Diagnosis of Early
Alzheimer’s DiseasedJapan
(SEAD-J) and Alzheimer’s
Disease Neuroimaging Initiative
(ADNI). The regions displayed in
red indicate signiﬁcant regional
hypometabolism (p<0.05). (A)
Correlation between lower Mini-
Mental Status Examination
(MMSE) scores and glucose
metabolism. (B) Correlation
between lower Logical Memory
subset of the Wechsler Memory
Scale Revised (WMS-R LM)
scores and glucose metabolism.
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Comparison of baseline proﬁles of MCI patients between SEAD-J and ADNIshowed an inverse correlation in bilateral medial frontal
regions (ﬁgure 4B).
Differences between AD converters and non-converters
In comparisons with AD conversion within 2 years, we
revealed the difference in proﬁles between converters
and non-converters (table 3). Patients who had dropped
out or returned to normal were excluded from statistical
analysis. In terms of patients to follow-up and patients
dropping out, the studies did not show any signiﬁcant
differences in clinical proﬁles. The conversion ratio
during 1 year was higher in SEAD-J than in ADNI (24.5%
vs 13.5%; c
2¼5.33, p<0.05). Conversely, conversion ratio
over 2 years showed no difference between studies
(SEAD-J, 35.6%; ADNI, 33.3%; c
2¼0.097, p¼0.77).
Comparing the baseline proﬁles associated with
Figure 4 Statistical parametric
mapping of the brain regions
correlated with baseline proﬁles in
Studies on Diagnosis of Early
Alzheimer’s DiseasedJapan
(SEAD-J) and Alzheimer’s
Disease Neuroimaging Initiative
(ADNI). The regions displayed in
red indicate signiﬁcant regional
hypometabolism (p<0.05). (A)
Inverse correlation between
Geriatric Depression Scale (GDS)
scores and glucose metabolism.
(B) Inverse correlation between
age and glucose metabolism.
Table 3 Differences in baseline proﬁles between the converters to AD and non-converters
SEAD-J ADNI
Conv/non-conv p Value Conv/non-conv p Value
1-year conversion
MMSE 25.361.3/26.661.9 0.002 26.861.8/27.2/1.7 NS
Modiﬁed MMSE 21.661.3/22.661.8 0.012 21.861.7/22.561.5 NS
WMS-R LM 0.761.3/1.961.8 0.003 2.562.3/4.262.7 0.004
GDS 4.362.0/4.262.4 0.003 1.361.4/1.761.4 NS
Age (yrs) 70.666.9/71.666.7 NS 75.566.1/75.767.3 NS
Education (yrs) 12.163.1/11.563.0 NS 15.862.8/15.962.9 NS
1e2-year conversion
MMSE 25.961.8/26.461.9 0.001 27.161.6/27.361.6 NS
Modiﬁed MMSE 22.161.5/22.562.0 NS 22.561.5/22.561.4 NS
WMS-R LM 1.661.9/1.961.9 NS 3.862.7/4.362.7 NS
GDS 4.962.6/3.962.1 NS 1.661.2/1.561.4 NS
AGE (yrs) 70.966.4/71.566.5 NS 73.767.6/75.966.8 NS
Education (yrs) 12.463.4/11.763.1 NS 16.662.5/15.862.9 NS
Values are mean6SD. 1-year conversion, AD conversion within 1 year after inclusion; 1e2-year conversion, AD conversion from 1 year to
2 years after inclusion.
AD, Alzheimer’s disease; ADNI, Alzheimer’s Disease Neuroimaging Initiative; Conv, AD converters; GDS, Geriatric Depression Scale; MMSE,
Mini-Mental Status Examination; non-conv, AD non-converters; NS, no signiﬁcance; SEAD-J, Studies on Diagnosis of Early Alzheimer’s
DiseasedJapan; WMS-R LM, Logical Memory subset of the Wechsler Memory Scale Revised.
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Comparison of baseline proﬁles of MCI patients between SEAD-J and ADNIconversion during 1 year of follow-up, SEAD-J converters
showed signiﬁcantly lower MMSE and WMS-R LM scores
than non-converters (p<0.01). In ADNI, WMS-R LM
score was lower in converters (p<0.01), but no differ-
ence in MMSE score was evident. Regarding the proﬁles
associated with conversion from 1 year to 2 years after
inclusion, MMSE score was lower for SEAD-J converters
than for non-converters (p<0.05). Among ADNI
converters, no proﬁles showed signiﬁcant differences.
DISCUSSION
From analyses of baseline proﬁles, SEAD-J included
patients with more severe verbal memory deﬁcits and
extracted patients with higher depressive tendencies
compared with ADNI. These differences in proﬁles of
MCI patients were likely to be associated with operating
criteria. In FDG-PET, both studies showed considerably
lower CMRgl in the regions preferentially affected by AD
and the frontal cortices. The baseline proﬁles provided
characteristic pattern of correlations between CMRgl on
baseline FDG-PET and scores of neuropsychological
tests.
Despite some studies have reported associations
between lower MMSE score of AD patients and higher Z
score in the regions preferentially affected by AD,
21 22
such associations in MCI patients have not been
demonstrated. In this study, MCI patients in SEAD-J had
association between hypometabolism in bilateral inferior
parietal regions and MMSE score. The modiﬁed MMSE
score showed same pattern of correlation (data not
shown). However, we could not ﬁnd any association
between MMSE score of patients in ADNI and CMRgl, as
a result of previous report.
23 In WMS-R LM score, SEAD-
J showed a weak regional correlation in the part of right
inferior parietal cortex, while ADNI showed correlations
in the precuneus and right dominant medialetemporal
cortices. These results might reﬂect difference in disease
severity of the patient samples, that is, how close an
individual is to a clinical transition to AD.
Concerning the hypometabolism in frontal cortices, it
might be an additional ﬁnding associated with the
conversion from MCI to AD.
8 In patients with depressed
mood disorders, an FDG-PET study has shown a lower
CMRgl in bilateral frontal and temporal cortices, inferior
parietal lobules and left cingulate cortex.
24 In AD
patients with depressive syndrome, a greater decrease of
CMRgl has been found in right suprafrontal lobules than
in non-depressive AD.
25 In our analyses, CMRgl in the
right dominant suprafrontal regions showed an inverse
correlation with GDS scores. In particular, the SEAD-J,
which included patients with higher depressive tenden-
cies, showed wider regions with correlation compared
with ADNI. Although the prevalence of patients with
depressive tendencies was not as high in SEAD-J, the
inclusion of patients with depressive tendencies might
affect CMRgl. In addition, CMRgl in medial frontal
regions showed an inverse correlation with age, indi-
cating the ageing effect of glucose metabolism,
26 or
possibly containing a partial volume effect.
27 These
results reﬂected patient demographics of each study.
In baseline proﬁles, high educational level was another
characteristic of patients in ADNI. The WMS-R LM score
for ADNI patients correlated with educational level. This
correlation was likely to be associated with categorical
inclusion criteria for educational level. High education
might mask expression of dementia symptoms. Several
studies have supported the hypothesis that highly
educated subjects tend to cope better with the onset of
dementia.
28e30 In FDG-PET studies, higher education
has been documented as a proxy for brain functional
reserve.
31 32 The impact of educational level might
complicate the interpretation of subtle changes in
neuropsychological test results for patients with high
education. A combination of neuropsychological testing
with FDG-PET might thus help the accuracy for AD
diagnosis in such cases. One study reported an associa-
tion between higher education and lower CMRgl in the
temporoparietal cortex and precuneus in AD and MCI
converters.
33 However, we did not ﬁnd evidence that
high education affected AD conversion in MCI patients.
The impact of education remains controversial and
might depend on the patient sample.
34
We revealed that SEAD-J patients exhibited a signiﬁ-
cantly higher rate of conversion within 1 year after
inclusion compared with ADNI. Deﬁcits in verbal
memory and psychomotor speed/executive function
abilities might be associated with conversion to AD.
35
Actually, in the present analyses, comparisons of baseline
proﬁles between AD converters and non-converters
revealed that SEAD-J converters had lower global
cognitive and verbal memory compared with ADNI
converters. Furthermore, in SEAD-J, AD converters
during 1 year after inclusion showed more severe CMRgl
reductions in bilateral inferior parietal regions
compared with converters during the following year.
Based on these results, the difference in AD conversion
ratio might be dependent on the severity of pre-
dementia AD, reﬂecting that MCI patients with severe
baseline memory deﬁcits rapidly converted to AD. It
suggested that inclusion and diagnostic criteria were
likely to be associated with the incidence of AD.
However, there was no difference in conversion ratio
seen within 2 years of follow-up period. Concerning the
discrepancy due to follow-up period, it is likely that the
difference in AD conversion ratio may not be limited by
criteria only but be affected by another factor such as
genotype in MCI population. The CMRgl reductions in
AD-associated regions have been reported in cognitively
normal people with the apolipoprotein E 34 allele,
a common AD susceptibility gene, many years before the
onset of symptoms of cognitive disturbance.
36 It suggests
that FDG-PET ﬁndings may associate with pathogenesis
of AD. Although our observation was too short to make
clear the impact of criteria and baseline proﬁles on the
risk of AD conversion, it is likely that the incidence of AD
may not have greater difference in groups with greater
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criteria as for prevalence in genotype.
In our analyses, these comparisons of different
multicenter studies have some limitations. Quality
control protocols for data acquisition caused different
pattern of CMRgl in comparison of FDG-PET between
SEAD-J and ADNI. We carried out the analyses
comparing the baseline FDG-PET between two studies.
However, the result contaminated non-speciﬁc changes
especially in the frontal and parietal regions. In this
reason, we presented the difference in glucose metab-
olism between MCI patients and normal subjects, in
each study. In addition, the present results were based
on data sets at the time of inclusion. To clarify further
association between each patient’s proﬁle and risk of
AD conversion, multimodal analyses of data are needed
for longer follow-up period.
In conclusion, our study revealed that the participants
of each study showed some differences in baseline
proﬁles because the two studies applied own original
inclusion criteria to MCI patients. SEAD-J had more
strict criteria to include patients with severe verbal
memory deﬁcits. The characteristics of baseline proﬁles
are closely related to AD conversion ratio within 1 year
after inclusion. Furthermore, we compared national
differences between multicentre studies to show that
inclusion criteria were associated with pattern of
regional glucose metabolism. We suggest that severity of
AD assessed by neuropsychological tests were a function
of the recruitment criteria. To evaluate the value of
neuroimaging measures in the early diagnosis of AD, the
results of multicenter studies, even though focusing on
amnestic MCI, should be compared carefully consid-
ering difference in characteristics of inclusion criteria
and proﬁles.
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